The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Enhanced plasma half life and efficacy of engineered human albumin fused GLP 1 despite enzymatic cleavage of its C terminal end Communications Biology Can You Take GLP 1 Forever? Long Term Considerations FDA Sends Warning Letter to Ozempic Maker Over Potential Unreported Side Effects GLP 1 Injections Clinic Near Me in Rock Hill, SC How Does Semaglutide Affect Your Menstrual Cycle?